NeoMTA® 2 1.0g Kit

NeoMTA® 2 · Avalon Biomed · 1.0 g kit

Pulp cappingPulpotomyApexificationResorptionPerforation repairRoot-end fillingObturation

Rinse it, restore it, send them home – same visit

The reason classic MTA cases so often need a second appointment is washout. You place the material, you cannot irrigate over it, you cannot condense a restoration onto it, so you dress the tooth and bring the patient back. Avalon's answer is blunt and it is in their own instructions: NeoMTA® 2 is immediately washout resistant – gently rinse and complete the restoration, or cement a crown, straight after placing it.

This pack: 1.0 g NeoMTA® 2 powder with water-based gel · 0.1 g scoop, so roughly ten typical doses
Made by Avalon Biomed · 3-year shelf life

“NeoMTA 2 is immediately wash-out resistant. You can gently rinse and complete the restoration or cement a crown, immediately after placing NeoMTA 2.”

Avalon Biomed, NeoMTA® 2 frequently asked questions (IFU-62).

One powder, two consistencies – and that is the whole point

NeoMTA® 2 is supplied as powder plus a water-based gel, and how much gel you add decides what you have made. That is the trade against a premixed putty: a little bench work in exchange for a material that covers repair and obturation from one jar.

The radiopacifier, and why it is not bismuth

Traditional MTAs use bismuth oxide to make the material visible on a radiograph, and bismuth is the accepted mechanism behind the grey shadow those materials can leave in a tooth. Avalon build on tantalum oxide – tantalite instead, which gives 6.5 mm Al equivalent radiopacity at putty consistency without the bismuth in the formulation at all.

Put plainly: removing bismuth removes the best-understood staining mechanism. No calcium silicate is immune to discolouration, and blood contamination at placement affects colour stability across the whole class – so get haemostasis first, whatever you are placing.

Clinical evidence

In a randomised clinical trial of 70 primary molars in 42 children, published in Pediatric Dentistry in 2023, NeoMTA® 2 achieved 100% clinical success (34 of 34) and 94.1% radiographic success (32 of 34) as a pulpotomy medicament at twelve months. The comparator arm – premixed NeoPUTTY® – came in at 97.1% and 92.8%, which the authors reported as comparable.

Alqahtani AS, Alsuhaibani NN, Sulimany AM, Bawazir OA. Pediatric Dentistry 2023;45(3):240–244.

That trial is primary molar pulpotomy at twelve months. The longer view comes from the predecessor formulation, NeoMTA® Plus – a different product from the one in this box, but the same chemistry lineage, and the follow-up runs to four years:

Taha NA, Al-Khatib H. Journal of Endodontics 2022;48(1):87–95. · Alsanouni M, Bawazir OA. Pediatric Dentistry 2019;41(2):107–111. Both studied NeoMTA® Plus, the predecessor formulation.

The four-year study is the one worth dwelling on, because it is the hardest case: symptomatic mature permanent teeth with carious exposure, where the textbook answer used to be root canal treatment. Its authors also found the strongest predictor of failure was not the material but severe preoperative pain – and that the coronal seal was critical to long-term survival.

The thirteen indications

Avalon list thirteen, and ask that you read the instructions for use before each application. In practice the ones that bring people to this material are direct and indirect pulp capping, partial pulpotomy and pulpotomy, apexogenesis and apexification, internal and external root resorption, perforation repair, root-end filling, and use as a cavity liner or base – plus obturation, when mixed to the thinner consistency.

Complete the system

Questions we actually get asked

NeoMTA® 2 or NeoPUTTY®?
If you want one material that can be a putty or a sealer, take this. If you never thin your MTA and would rather skip the slab entirely, take the putty. The randomised trial found their pulpotomy outcomes comparable, so choose on handling, not on efficacy.

Can I really restore in the same visit?
That is Avalon's own instruction, quoted above. Follow the instructions for use for your indication – and note that the material is washout resistant immediately, which is not the same as fully set.

How many cases will 1.0 g cover?
The scoop is 0.1 g, so roughly ten typical doses. Avalon quote 25 doses for the 2.5 g kit, which is the better buy if MTA is routine for you.

Does it contain bismuth?
No – the radiopacifier is tantalum oxide. If a specific formulation question matters for your case, ask us and we will get it in writing from Avalon rather than paraphrasing a brochure.

NeoMTA® 2 1.0 gm Kit · tricalcium and dicalcium silicate powder with water-based gel · tantalite radiopacifier · 6.5 mm Al · immediately washout resistant · 0.1 g scoop · 3-year shelf life · Avalon Biomed · REF N2100